MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The Role Imposed by The High-Mobility Group Box 1 (HMGB1) Protein in MPTP-Induced Zebrafish Model of Parkinson’s Disease

    K. Razali, WMY. Mohamed, N. Othman, MHM. Nasir, AA. Doolanea, J. Kumar (Kuantan, Malaysia)

    Objective: This study aims to investigate the role of HMGB1 protein in mediating neuroinflammatory-induced parkinsonian movement disorder of the MPTP-induced zebrafish model of Parkinson's disease…
  • MDS Virtual Congress 2021

    Biomarker candidates – Peptides identified to be differentially abundant in cerebrospinal fluid of patients with Parkinson´s disease

    L. Schilde, B. Serschnitzki, F. Maass, M. Bähr, P. Lingor, C. May, K. Marcus (Bochum, Germany)

    Objective: The aim of this study was to identify cerebrospinal fluid peptides that are differential in the cerebrospinal fluid of patients with Parkinson´s disease. Those…
  • MDS Virtual Congress 2021

    Metabolic alterations in a Drosophila model of Parkinson’s disease

    C. Solana-Manrique, F J. Sanz, I. Torregrosa, N. Paricio (Burjassot, Spain)

    Objective: Identification of metabolic alterations that could be contributing to Parkinson’s disease (PD) physiopathology and become new biomarkers or therapeutic targets for the disease. Background:…
  • MDS Virtual Congress 2021

    Whole-transcriptome analysis of monocyte-derived macrophages from patients with Parkinson’s disease associated with mutations in the GBA gene

    T. Usenko, A. Panteleeva, K. Basharova, M. Nikolaev, A. Kopytova, A. Bezrukova, K. Senkevich, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: To understand specific molecular features of Parkinson’s disease associated with mutations in the GBA gene (GBA-PD), we analyzed the gene expression profile of peripheral-blood…
  • MDS Virtual Congress 2021

    Functional connectivity as an early marker of indication for deep brain stimulation treatment in Parkinson’s disease (PD)

    L. Albano, F. Agosta, S. Basaia, C. Cividini, T. Stojkovic, E. Sarasso, I. Stankovic, A. Tomic, V. Markovic, E. Stefanova, P. Mortini, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To identify functional neuroimaging patterns anticipating the clinical indication for deep brain stimulation (DBS) in patients with PD. Background: DBS has become a well-established…
  • MDS Virtual Congress 2021

    Motor cerebro-cerebellar networks breakdown among different subtypes of Parkinson’s disease

    S. Basaia, F. Agosta, A. Francia, C. Cividini, T. Stojkovic, I. Stankovic, R. de Micco, L. Albano, E. Sarasso, A. Gardoni, N. Piramide, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: The aim of this study was to investigate functional alterations within motor circuits of the cerebro-cerebellar system in tremor-dominant (TD) and postural instability and…
  • MDS Virtual Congress 2021

    Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

    S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To determine whether hippocampal subfield volumes in non-demented Parkinson’s Disease (PD) are primarily predicted by cognition or CSF β-amyloid 1–42 (Aβ42) levels. Background: The…
  • MDS Virtual Congress 2021

    Longitudinal change in thalamic white matter macrostructure and volume in Parkinson’s disease depression

    R. Bhome, A. Zarkali, J. Cole, R. Weil (London, United Kingdom)

    Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is the most common neuropsychiatric feature of…
  • MDS Virtual Congress 2021

    Interest of optical coherence tomography in Parkinson’s disease

    N. Chtaou, S. Bouchal, A. El Midaoui, Z. Souirti, M F. Belahsen, M. Bouhlal (Fez, Morocco)

    Objective: To compare optical coherence tomography (OCT) results of retinal thickness (RT) and retinal nerve fiber layer (RNFLT) thickness of patients with idiopathic Parkinson's disease…
  • MDS Virtual Congress 2021

    Perivascular spaces in the basal ganglia and long-term motor prognosis in newly diagnosed Parkinson’s disease

    SJ. Chung, YJ. Kim, PH. Lee, YH. Sohn (Yongin-Si, Republic of Korea)

    Objective: To investigate the association between enlarged perivascular spaces (PVSs) in the basal ganglia (BG-PVSs) and long-term motor outcomes in Parkinson’s disease (PD). Background: PVSs…
  • « Previous Page
  • 1
  • …
  • 773
  • 774
  • 775
  • 776
  • 777
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley